FOXD1 and adrenal cortex carcinoma: For DSS, higher FOXD1 expression was significantly associated with reduced DSS in ACC (P=0.0013), BLCA (P=0.016), COAD (P=0.025), HNSC (P=0.00011), KIRC (P=0.00072), KIRP (P<0.0001), LGG (P<0.0001), MESO (P=0.00092), PAAD (P=0.021), and UVM (P=0.0044) (Figure 3A–J).